VBL Therapeutics to Present Data on its Novel VB-600 Platform at Keystone Conference on February 26

Ads

You May Also Like

Foresight 4 VCT plc – Half-year report

FORESIGHT 4 VCT PLC Summary Diversified portfolio of 21 actively managed companies.Net Asset Value ...

ADMA Biologics Announces Proposed Public Offering of Common Stock

RAMSEY, N.J., April 27, 2016 (GLOBE NEWSWIRE) -- ADMA Biologics, Inc. (NASDAQ:ADMA), a late-stage ...